在异性β-thalassemia中的血液学比率和细胞因子概况
Ana Carolina Marques Ciceri1, Laura Eduarda de Oliveira1, Ana Luísa Richter1
1Universidade Federal de Santa Maria, Departamento de Análises Clínicas e Toxicológicas, Laboratório de Pesquisas em Análises Clínicas Aplicadas - LAPACA, Santa Maria, RS, Brazil.
Hematology, transfusion and cell therapy
|May 14, 2025
概括
异构性β-血病特征 (hBTh) 携带者表现出高度的炎症特征,具体血液学比率表明. 这些比率为监测hBTh患者提供了一种实用方法.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- β-Thalassemia是一种遗传性疾病,其特征是减少或缺少β-环球蛋白合成,导致溶血性贫血.
- 异卵性β-血病特征 (hBTh) 是最温和的形式,通常无症状,但与免疫系统变化相关.
- 在hBTh载体中观察到白细胞,中性粒细胞和淋巴细胞数量的增加.
研究的目的:
- 为了评估hBTh载体中的免疫和炎症标志物.
- 评估了各种血液学比率,包括中性粒细胞/淋巴细胞和血小板/淋巴细胞比率.
- 研究了全身免疫炎症和炎症反应指数,以及炎症性细胞因子.
主要方法:
- 追溯观察性研究设计.
- 包括50名具有β-血病特征的个体和100名健康对照.
- 分析了白细胞计数,网状细胞计数,白蛋白-6水平以及各种炎症标志物.
主要成果:
- hBTh载体的白细胞,中性粒细胞和网细胞数量较高,并增加了interleukin-6水平.
- 在hBTh组中观察到中性粒细胞/血小板,中性粒细胞/淋巴细胞和衍生中性粒细胞/淋巴细胞比率的增加.
- 系统性免疫炎症和系统性炎症反应指数在hBTh载体中显著更高.
结论:
- β-thalassemia 特性与一个独特的炎症特征相关.
- 血液学比率作为潜在的成本效益和易于应用的标志物用于监测hBTh.
- 这些标志物可以帮助理解和管理hBTh.Th的炎症方面.
相关概念视频
Multiple Allele Traits
33.8K
The Concept of Multiple Allelism
33.8K
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Blood Types
17.1K
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
17.1K
Bone Marrow Sampling and Transplants
265
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
265
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Hematopoiesis
4.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
4.9K


